Essex LLC Bristol Myers Squibb CO Transaction History

Essex LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$40.25 - $52.99 $10,022 - $13,194	-249 Reduced 2.89%	8,373 $347,000
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $34,305 - $38,896	-715 Reduced 7.66%	8,622 $467,000
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $58,903 - $70,287	-1,215 Reduced 11.51%	9,337 $479,000
Q3 2023 Oct 16, 2023	SELL	$57.89 - $64.73 $129,557 - $144,865	-2,238 Reduced 17.5%	10,552 $612,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $157,937 - $175,364	-2,479 Reduced 16.24%	12,790 $817,000
Q4 2022 Jan 30, 2023	SELL	$68.48 - $81.09 $56,632 - $67,061	-827 Reduced 5.14%	15,269 $1.1 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $2,406 - $1.42 Million	-18,514 Reduced 53.49%	16,096 $1.14 Million
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $12,926 - $14,236	-178 Reduced 0.51%	34,610 $2.67 Million
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $37,933 - $45,485	617 Added 1.81%	34,788 $2.54 Million
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $198,699 - $231,636	3,705 Added 12.16%	34,171 $2.13 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $1.8 Million - $2.11 Million	30,466 New	30,466 $1.8 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

Stay updated on Essex LLC with notifications on news.